Components of day-to-day variability of cerebral perfusion measurements – Analysis of phase contrast mapping magnetic resonance imaging measurements in healthy volunteers by Ismaili, Abd R.A. et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Components of day-to-day variability of cerebral perfusion measurements – Analysis
of phase contrast mapping magnetic resonance imaging measurements in healthy
volunteers
Ismaili, Abd R.A.; Vestergaard, Mark B.; Hansen, Adam E.; Larsson, Henrik B.W.;
Johannesen, Helle H.; Law, Ian; Henriksen, Otto M.
Published in:
PLoS ONE
DOI:
10.1371/journal.pone.0197807
Publication date:
2018
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Ismaili, A. R. A., Vestergaard, M. B., Hansen, A. E., Larsson, H. B. W., Johannesen, H. H., Law, I., & Henriksen,
O. M. (2018). Components of day-to-day variability of cerebral perfusion measurements – Analysis of phase
contrast mapping magnetic resonance imaging measurements in healthy volunteers. PLoS ONE, 13(6),
[e0197807]. https://doi.org/10.1371/journal.pone.0197807
Download date: 03. Feb. 2020
RESEARCH ARTICLE
Components of day-to-day variability of
cerebral perfusion measurements – Analysis
of phase contrast mapping magnetic
resonance imaging measurements in healthy
volunteers
Abd R. A. Ismaili1, Mark B. Vestergaard1, Adam E. Hansen1, Henrik B. W. Larsson1,2, Helle
H. Johannesen1, Ian Law2, Otto M. Henriksen1*
1 Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet Blegdamsvej, University of
Copenhagen, Copenhagen, Denmark, 2 Institute for Clinical Medicine, The Faculty of Health and Medical
Sciences, University of Copenhagen, Copenhagen, Denmark
* ohen0009@regionh.dk
Abstract
Purpose
The aim of the study was to investigate the components of day-to-day variability of repeated
phase contrast mapping (PCM) magnetic resonance imaging measurements of global cere-
bral blood flow (gCBF).
Materials and methods
Two dataset were analyzed. In Dataset 1 duplicated PCM measurements of total brain flow
were performed in 11 healthy young volunteers on two separate days applying a strictly
standardized setup. For comparison PCM measurements obtained from a previously pub-
lished study (Dataset 2) were analyzed in order to assess long-term variability in an aged
population in a less strictly controlled setup. Global CBF was calculated by normalizing total
brain flow to brain volume. On each day measurements of hemoglobin, caffeine and glucose
were obtained. Linear mixed models were applied to estimate coefficients of variation (CV)
of total (CVt), between-subject (CVb), within-subject day-to-day (CVw), and intra-session
residual variability (CVr).
Results
In Dataset 1 CVt, CVb, CVw and CVr were estimated to be 11%, 9.4%, 4% and 4.2%, respec-
tively, and to 8.8%, 7.2%, 2.7% and 4.3%, respectively, when adjusting for hemoglobin and
plasma caffeine. In Dataset 2 CVt, CVb and CVw were estimated to be 25.4%, 19.2%, and
15.0%, respectively, and decreased to 16.6%, 8.2% and 12.5%, respectively, when adjust-
ing for the same covariates.
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Discussion
Our results suggest that short-term day-to-day variability of gCBF is relatively low compared
to between-subject variability when studied in standardized conditions, whereas long-term
variability in an aged population appears to be much larger when studied in less a standard-
ized setup. The results further showed that from 20% to 35% of the total variability in gCBF
can be attributed to the effects of hemoglobin and caffeine.
Introduction
Quantitative measurements of global cerebral blood flow (gCBF) are of general interest both
for basic physiological investigations and for our understanding of brain aging and the patho-
physiology of brain diseases [1] Many brain diseases are associated with altered gCBF, and sev-
eral studies have reported that decreased total brain flow or gCBF may be associated with
severity of vascular lesions and brain atrophy [2], impaired cognitive function [3] and may
even predict overall future mortality in old age [4]. However, in order to fully interpret these
results, more detailed knowledge of the normal variability between and within individuals is
required.
Previous studies investigating variability of gCBF measurements have mainly focused on
separating between-subject variability from residual intra-session variability considered to
reflect method imprecision [5–7]. These studies have confirmed large and similar between-
subject variability, whereas intra-session variability varies substantially depending on the
method applied. However, when obtaining measurements at two different time-points, the
within-subject variability consists of both the true inter-session (day-to-day) variability and
the intra-session variability (imprecision). Little is known about the normal temporal variabil-
ity of gCBF and the factors influencing this variability. Like most other physiological parame-
ters gCBF is expected to exhibit temporal variations, probably with both high-frequency
(seconds to minutes) variations reflecting variations in blood pressure and respiration pattern
[8], low frequency variations related to diurnal variations [9] and sleep [10], very low fre-
quency variations related to menstrual cycle [11], and also age related changes [12]. Accord-
ingly, intra-subject variability is expected to increase over time and may also depend on both
the population studied and the experimental setup.
In cross-sectional studies it is of key interest to know how representative a single gCBF
measurements is for a particular participant, i.e. how much would gCBF vary if the measure-
ment was obtained on a different day? Establishing normal variability over time is therefore
essential for interpreting the association of gCBF with various factors or of temporal changes
in gCBF, and such knowledge is also useful for planning studies involving measurement of
gCBF.
It is generally assumed that cerebral metabolic rate of oxygen should be relatively constant
during resting awake conditions, and consequently the delivery of oxygen to the brain should
exhibit low temporal variability [13]. However, a number of factors may influence the relation-
ship between cerebral blood supply and metabolism. The hemoglobin concentration has been
shown to be a major determinant of gCBF [14], but is expected to show minimal temporal var-
iability and thus mainly influence between-subject variability. In contrast, caffeine, which is
widely consumed in the public, may decrease gCBF by up to 30% after dietary intake in normal
quantities [15, 16], and may thus be an important cause of day-to-day variation in gCBF [17].
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The aims of this study were to estimate the components of the day-to-day variability of
repeated measurements of gCBF and to assess the influence of hemoglobin and plasma caffeine
levels on these components. Further, we wished to compare variability of short-term repeated
measurements obtained in strictly controlled conditions with long-term variability in an aged
population under less well-controlled conditions.
Materials and methods
Day-to-day variability was investigated in two separate datasets. In Dataset 1 short-term vari-
ability was investigated in healthy young male volunteers examined in standardized conditions
with duplicate PCM measurements performed on each of two study days < 2 weeks apart. In
Dataset 2 long term-variability was assessed from single PCM measurements in elderly,
healthy volunteers performed on two study days> 3 months apart. Data are provided as sup-
porting information (S1 Data).
Both studies were approved by the Scientific Health Ethics Committee of the Capital region
of Denmark (Ref. H-D-2008-002 and H-B-2008-075) following the standards of The National
Committee on Health Research Ethics, and were conducted in accordance with the Helsinki
Declaration. All volunteers gave informed written consent.
Dataset 1
Subjects. A total of 12 healthy young male volunteers were included in the study (mean
age 24 [range 21 to 28] years). One participant was subsequently excluded due to a detected
structural abnormality. Eligible subjects had a caffeine intake of 1–5 cups of tea or coffee daily.
Exclusion criteria comprised prior incidents of severe head trauma, a history of neurological,
psychiatric, or endocrine disorders, or contraindications to MRI.
Study design. Duplicate measurements of total brain flow were performed on two sepa-
rate days (1–16 days apart) using an identical imaging protocol. Venous blood samples were
collected on each study day and analyzed for hemoglobin, glucose and caffeine. All scans were
performed during the daytime by the same researcher (A.I).
MRI experiment. MRI scans were performed on a 3T hybrid PET/MR system (Biograph
mMR, Siemens Healthcare, Erlangen, Germany) using a 16 channel receive head-neck coil.
On each day MRI measurements were conducted within a single session of approximately 45
minutes. Participants were instructed to abstain from coffee or other methylxanthine contain-
ing beverages or food items six hours prior the experiment, and not to consume any food two
hours prior to the scan.
Initially a 3D inflow angiogram (64 slices per slab, voxel size 1.4×1.0×1.66 mm, TE = 6.04
ms, TR = 39.90 ms, flip angle 15˚) of the cerebral vessels was obtained. Based on coronal and
sagittal maximal intensity projections the PCM measurement slice was placed as perpendicular
as possible to the vertebral and internal carotid arteries at the level of the third vertebral artery
segment (Fig 1). Measurements were obtained with the following parameters (1 slice, slice
thickness = 5.0 mm, voxel size 0.8×0.8×5.0 mm, TE = 3.38 ms, TR = 37.40 ms, flip angle 25˚, 6
measurement, encoding velocity = 150 cm/s). The sequence was pulse triggered (retrospective
gaiting 20 frames/cycle).
On one of the study days a structural scan for tissue segmentation and calculation of brain
volume was acquired using a 3D T1 weighted gradient echo sequence (TR = 1900 ms,
TE = 2.44 ms, flip angle 9˚, voxel size: 1.0×1.0×1.0 mm3).
Image and data processing. PCM data were processed using in-house software based on
Matlab (Mathwoks, Natick, MA). Regions of interest were manually drawn around the internal
carotid and vertebral arteries on the mean velocity image (Fig 1). Flow in each vessel was
Components of day-to-day variability of cerebral perfusion measurements
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calculated by multiplying mean velocity with vessel area and integrating over time. All process-
ing was performed by the same investigator (A.I.).
For calculation of brain volume, the 3D T1 weighted scan was converted into NIfTI format
and analyzed using the FSL tools BET and FAST (FMRIB Software Library, Oxford University,
Oxford, UK). Total brain volume was calculated as the sum of the white and grey tissue vol-
umes including also cerebellum and brain stem. Mean gCBF was calculated as the sum of
flows (ml/min) in the four arteries (total blood flow) divided by the brain volume, and
reported in ml/100ml/min. The same segmented scan and brain volume was used for calcula-
tion of all gCBF values in each participant.
Dataset 2
Repeated PCM measurements obtained as a part of a previously published study were analyzed
for comparison. Single PCM measurements were performed on two study days> 3 months
apart (range 140 to 252 days) in 13 aged healthy volunteers (6 men / 7 women, age 52–68
years) [18]. Repeated measurements have not been published previously. Study populations
characteristics and experimental design including MRI sequence parameters and post-process-
ing have been described in details previously [18]. Estimates of intrasession variability (CVr)
was obtained from a previous study of young healthy volunteers [7]. Both studies were per-
formed on a 3T Philips Achiva MR system using very similar imaging protocols (details are
provided in S1 Table). Triggered PCM measurements of the basilar and internal carotid arter-
ies were analyzed using in-house software based on Matlab. Brain volume was obtained from a
3D T1 scan as described above.
Fig 1. Planning and analysis of phase contrast mapping measurements in Dataset 1. Top panel shows planning of
the PCM measurement slice (yellow line) on sagittal (left) and coronal (right) maximum intensity projections of
cerebral arteries. Lower panels shows color coded velocity maps. The right (red) and left (blue) cerebral arteries are
clearly visible on the mean velocity image. Lower right panel shows manually drawn regions of interest corresponding
to each artery.
https://doi.org/10.1371/journal.pone.0197807.g001
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Participants were allowed to consume coffee and tea as usual, and blood samples for deter-
mination of plasma caffeine, blood hemoglobin and plasma glucose were obtained and ana-
lyzed as described above.
Statistical analysis
All statistical analysis was performed using SAS version 9.4 (SAS Institute Inc., Cary, NC).
Repeatability of repeated measurements was assessed by a Bland-Altman analysis, and a paired t-
test was applied for significance testing of bias. In Dataset 1 we investigated both intra-session
repeatability on study day 1 (measurement 1- measurement 2) and inter-session (or day-to-day)
repeatability (measurement 1 day 1—measurement 1 day 2). For simplicity and for comparabil-
ity with Dataset 2, only repeatability of the first measurement on day 1 is reported in Bland-Alt-
man analysis, whereas all measurements were include in the mixed linear model below.
Total variance (s2t ) is the sum of between-subject (s
2
b), within-subject (s
2
w) and residual (s
2
r )
variance:
s2t ¼ s
2
b þ s
2
w þ s
2
r
These variance components can be estimated along with regression coefficients of covariates
using by applying a 3-level mixed linear model with subject (level 3) and day (within-subject,
level 2) as random effects (and replicate measurement as residual, level 1), and measurement
number and study day as fixed effects:
gCBFi;j;k ¼ gCBFpop þmeasurement þ day þ di þ zi;j þ εi;j;k;
where gCBFpop represents the population mean and δi, zj,i and εi,j,k denote mean off-set of the
i’th subject from population mean, offset from subject mean on the j’th day, and off-set of the
k’th measurement from the subject day mean, respectively. Each of these random components
can be described by a normal distribution with mean value of zero and a standard deviation of
σb, σw, σr., respectively. The corresponding coefficients of variation (CVt, CVb, CVw and CVr)
can be calculated as the standard deviation (σ) of each component divided by the mean value
of all measurements. To assess the effects of co-variates on variability, hemoglobin and caffeine
were successively added to the model as fixed effects. No effect of glucose on gCBF was
observed, and glucose was not included in the final models.
Dataset 2 was analyzed as above, except that a 2-level linear mixed model was applied with
study day as fixed effect. An additional model including also caffeine and hemoglobin as fixed
effects was also investigated. A similar model was applied to data from ref. [7] (including only
data from the 14 participants with duplicate measurements) to estimate same-day s2r and s
2
w.
In Dataset 2 residual variance equals the sum of s2r and s
2
w, i.e. the total within-subjects vari-
ance (s2tw) Under the assumption that method precision (intra-session CVr) is of similar rela-
tive size in Dataset 2 as in ref. [7], we can obtain an estimate of s2r in Dataset 2 (by multiplying
population mean in Dataset 2 with CVr determined from data in ref. [7]) which in turn can be
subtracted from σtw2 in Dataset 2 in order to obtain an estimate of s2w taking methods precision
into account.
Results
Dataset 1
All volunteers completed successfully both study days. Data from one participant on one study
day were excluded due to poor quality of PCM measurements. Characteristics of participants
and MRI mean results are presented in Table 1.
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The Bland-Altman analysis showed slightly poorer day-to-day repeatability compared to
within-day repeatability (Fig 2A and 2B) No significant bias between repeated measurements
was observed.
In the final linear mixed model gCBF was inversely correlated with hemoglobin (-7.08 [95%
CI: -11.35 to -2.82] ml/100ml/min per mmol/l, p = 0.002), and tended also to be inversely
Table 1. Mean study population values.
Dataset 1 Dataset 2
Mean ± SD Range Mean ± SD Range
Hemoglobin (mmol/l) 9.3 ± 0.6 7.8–9.9 8.7 ± 0.6 7.6–9.9
Plasma caffeine (μmol/l) 0.70 (0.14–1.26)† 0.03–9.6 25.3 (8.3–32.0)† 0.01–108
Glucose (mmol/l) 4.8 ± 0.5 3.8–6.3 5.6 ± 0.8 4.0–7.6
Height (cm) 183.3 ± 6.1 174–196 169.6 ± 10.0 156–186
Weight (kg) 82.0 ± 12.0 65–98 77.2 ± 16.0 57–116
Body mass index (kg/m2) 24.3 ± 2.8 20.3–28.7 26.5 ± 3.5 22.3–34.3
Brain volume (ml) 1157.1 ± 71.8 1033–1270 1073.0 ± 103.8 888–1242
Total blood flow (ml/min) 733.5 ± 88.3 566.5–915.1 539.58 ± 145.9 305.6–791.9
Cerebral blood flow (ml/100ml/min) 63.4 ± 6.9 50.5–76.6 50.5 ± 13.6 25.4–74.4
†Median (interquartile range).
https://doi.org/10.1371/journal.pone.0197807.t001
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Fig 2. Repeatability of cerebral blood flow measurements. Scatter plots (left) and Bland-Altman plots (right) of repeated
measurements from Dataset 1 (top panels) and Dataset 2 along with same-day measurements in young volunteers from ref. [7] (lower
panels). Both measurements obtained on the same day (blue circles) and on different days (red circles) are shown. The dashed line in the
scatter plots represents the line of identity and the dashed lines in the Bland-Altman plots represents the intra-session (blue) and inter-
session (red) upper and lower limits of repeatability.
https://doi.org/10.1371/journal.pone.0197807.g002
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associated with caffeine (-0.98 [95%CI: -2.19 to 0.24] ml/100ml/min per μmol/l, p = 0.107).
Excluding a single outlying and influential measurement (with very high caffeine levels and
low gCBF), the effect of caffeine on gCBF was further attenuated. Also, as the changes in
plasma caffeine between days were all close to zero, no association of change in plasma caffeine
with change in gCBF could be demonstrated (Fig 3).
The effects of adjusting for hemoglobin and caffeine on the total and individual compo-
nents of variability are presented in Table 2. Generally, CVb was found to be much larger than
CVw which in turn was slightly lower than CVr.
CVt decreased by 20% when including all covariates in the model. The reductions in total
variability were predominantly due to corresponding reductions in CVb, which decreased by
23%. The inclusion of caffeine did only result in a small decrease in CVw. Otherwise no effects
on CVw or CVr were observed.
Dataset 2
Bland-Altman analysis showed fair repeatability of gCBF measurements, but showed also
much wider limits of repeatability in long-term compared to intra-session repeated measure-
ments (Fig 2C and 2D). Mean gCBF on day 2 was lower than on day 1 (46.7 vs 54.4, p = 0.045).
Analysis of variance components (Table 2) showed that long-term variability is considerably
higher than intra-session variability, also when including covariates in the model. CVt
decreased by 35% when adjusting for caffeine and hemoglobin. Highly significant inverse asso-
ciations of gCBF with both hemoglobin (-11.41 [95%CI: -17.63 to -5.20] ml/100ml/min per
R2=0.20 , p=0.131
−20
−10
0
10
20
30
C
ha
ng
e 
gC
B
F 
(d
ay
1 
− 
da
y 
2)
 [m
l/1
00
m
l/m
in
]
−20 0 20 40
Change plasma caffeine (day1 − day 2) [micromol/l]
Fig 3. Influence of caffeine on day-to-day gCBF changes. Scatter plot showing change in gCBF and in plasma caffeine from day 1 to
day 2 in standardized caffeine abstained state (Dataset 1, blue circles) and in spontaneous caffeinated state (Dataset 2, red circles and
regression line). From Dataset 1 only the first measurement from each day is included.
https://doi.org/10.1371/journal.pone.0197807.g003
Components of day-to-day variability of cerebral perfusion measurements
PLOS ONE | https://doi.org/10.1371/journal.pone.0197807 June 7, 2018 7 / 13
mmol/l, p = 0.001) and plasma caffeine (-0.25 [95%CI: -0.42 to 0.08] ml/100ml/min per μmol/
l, p = 0.006) were found. Excluding measurements with very high caffeine levels (>60 μmol/l),
the effects of caffeine remained significant (p = 0.031). Also, a non-significant inverse associa-
tion of change in gCBF with change in plasma caffeine between the two study days was noted
(Fig 3).
Discussion
Knowledge on the normal variability of cerebral perfusion measurements is crucial when plan-
ning and designing studies involving such measurements, and is also important when inter-
preting studies addressing cerebral perfusion. In order to understand the sources of variability
of serial gCBF measurements in more details, we analyzed repeated PCM measurements in
healthy volunteers obtained on two separate days. The main findings are that short-term day-
to-day variability assessed under strictly controlled conditions in a homogenous population in
whom low variability is expected, was found to be small and in the same range as residual
intra-session variability. In contrast, long-term variability is much higher when studied in an
aged population under less standardized conditions. We also found that from 20% to 35% of
the total variability of short-term repeated gCBF measurements can be attributed to important
covariates mainly influencing between-subject variability.
The mean and range of both total brain flow and gCBF measurements were similar to those
previously reported in studies of young and aged subjects using PCM MRI [7, 18–20]. The
mean CBF value in young males (Dataset 1) of 63.4 ml/100ml/min corresponds to 60.4 ml/
100g/min when assuming a brain tissue density of 1.05 g/ml [21] which is somewhat higher
than the classical text book value of 50 ml/100g/min derived from other techniques [22]. This
overestimation is probably related to partial volume effects due to the low resolution of PCM
relative to vessel size resulting in overestimation of flow in smaller vessel, in particular in verte-
bral and basilar arteries [23, 24]. Also, small systematic error may result depending on the level
of PCM measurements as flow intended for small extracerebral branches is included when
measuring at the level of vertebral arteries (as in Dataset 1), whereas cerebellar braches from
the vertebral arteries is not included when measuring at the level of the basilar artery (as in
Dataset 2). In the aged population (Dataset 2) we found a mean gCBF of 50.5 ml/100 ml/min
Table 2. Variance components of day-to-day variability of gCBF measurements.
gCBF Variability
Mean σb σw σr CVb CVr CVw CVt
(ml/100ml/min)
Dataset 1
No covariates 64.3 5.9 2.5 2.6 9.4% 4.2% 4.0% 11.0%
Hgb 64.3 4.8 1.9 2.6 7.7% 4.2% 3.0% 9.2%
Hgb+caffeine 64.3 4.5 1.7 2.7 7.2% 4.3% 2.7% 8.8%
Dataset 2
No covariates 50.5 9.69 - 8.37 19.2% - 15.0%† 25.4%
Hgb+caffeine 50.5 4.14 - 7.27 8.2% - 12.5%† 16.6%
Data from ref. [7]
No covariates 64.9 10.98 - 4,63 16.9% 7.1% - 18.4%
†Estimated using CVr from ref. [7], see statistics section.
Abbreviations: gCBF = global cerebral blood flow, σ = standard deviation, CV = coefficient of variation, Hgb = hemoglobin. Subscripts b, r and w refer to between-
subject variability, residual variability and within-subject variability, respectively.
https://doi.org/10.1371/journal.pone.0197807.t002
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(or 48.1 ml/100g/min) which is very similar to the value of 51.2 ml/100ml/min previously
reported in a large aged, mixed gender population [20]. The lower gCBF values found in aged
subjects compared to younger subjects is thus in agreement with previous publications apply-
ing PCM and probably reflects mainly a true age related gCBF decline also reported using a
range other techniques [12, 25, 26] and in lesser degree methodological bias.
In terms of intra-session repeatability our results are also in agreement with previous stud-
ies [7, 19, 27] confirming excellent intra-session repeatability. As expected, the repeatability
between days tended to be poorer compared to sequential same day measurements. Previous
studies on PCM day-to-day repeatability have not included duplicate measurements [19, 28],
and accordingly could not separate methodological imprecision from true variability. One
study of MRI measurements of CMRO2 including duplicate PCM measurements performed at
five sessions within a two week period reported intra-session and inter-session and inter-sub-
ject CV of gCBF to 2.8%, 7.5% and 17.4%, respectively [29]. Due to differences in the calcula-
tion of CV, these CV values cannot be compared directly with those reported in the present
study.
The present study aimed to quantify true day-to-day variability. In Dataset 1 we found that
for short-term repeated measurements this component to be relatively small compared not
only to between-subject variability, but also at the same level or slightly lower than the residual
intra-session variability. This finding suggests that resting gCBF is relatively constant over
time when examined in standardized conditions in a homogenous population with expected
low within-subject variability. From Dataset 2 it appears that even when taking important
physiological covariates and method imprecision into account, long-term variability estimated
in an aged and more heterogeneous population, and applying a less strictly controlled experi-
mental setup, is as expected much higher compared to short-term day-to-day variability. The
higher CVw in Dataset 2 may be attributed to a number of factors. Notably, as shown in Fig 2D
large gCBF changes >20 ml/100ml/min were observed in three participants suggesting that
the higher variability may partially be attributed to large single subject changes related to hor-
monal [11] or other factors not accounted for in the present analysis. Other potential sources
related to the applied techniques, study design and the effects of caffeine are addressed below.
The residual intra-session variability (CVr) was as expected lower than between subject var-
iability (CVb). The unadjusted gCBF CVb of 9.4% in the Dataset 1 is lower than the values esti-
mated from Dataset 2 including both males and females, whereas it is only slightly lower than
the value of 11.6% reported in a recent study also including only young males [24]. Also the
CVr of 4% is lower than the values of 7.1% in ref. [7] and of 6.5% reported previously [24]. The
lower residual variability is most likely due to the longer acquisition time of the PCM measure-
ments in the present study. Further, it should be noted that in Dataset 2, measurements were
performed at the level the basilar artery which may be less straight and less parallel to the ICAs
and thus compromise both accuracy and precision.
Variable planning may influence day-to-day variability. In Dataset 1, a screen dump of
planning from day 1 was available when planning PCM on day 2, whereas in Dataset 2 plan-
ning was based on the general criteria used in our laboratory. A recent study suggested that
applying an automatic PCM planning algorithm may reduce residual variability compared to
manual planning [28] and could be of particular value in studies involving repeated PCM mea-
surements. It is thus possible that more variable planning may have contributed to the higher
CVw in Dataset 2 compared to Dataset 1.
Caffeine withdrawal can increase gCBF and caffeine intake can decrease gCBF [17, 30];
effects that may depends on daily caffeine intake suggesting that cerebral perfusion is adapted
to habitual caffeine levels. Therefore, instructing study participants to abstain from their habit-
ual caffeine intake is actually an intervention that might influence the measurements [17, 31].
Components of day-to-day variability of cerebral perfusion measurements
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Both in Dataset 1 and Dataset 2 day-to-day variability (CVw) decreased only slightly when
including caffeine in the model. As suggested by Fig 3, caffeine abstinence (Dataset 1) appears
to effectively reduce plasma caffeine day-to-day variability and associated gCBF changes com-
pared to the spontaneous caffeinated state (Dataset 2), although the association of plasma caf-
feine change with gCBF change was not significant. It is also remarkable that even if
participants were asked to abstain from caffeine before the experiment, plasma caffeine levels
up to 10 μmol/l were observed. Whether this reflects lack of compliance or variable metabo-
lism is not clear, but similar observations have been made in patients undergoing myocardial
perfusion imaging [32].
Also in agreement with previous studies, we found hemoglobin to an important determi-
nant of cerebral perfusion [14]. With increasing hemoglobin levels, lower gCBF is required to
maintain a constant cerebral oxygen delivery (and vice versa). Adjusting for hemoglobin did
not reduce residual intra-session variability as hemoglobin was relatively constant. However,
in other studies involving interventions that might change hemoglobin or when larger within
variability could be expected, e.g. repeated measurements in pre-menopausal women, adjust-
ing for hemoglobin would be relevant.
The present study has some limitations. First of all, sample size in Dataset 1 was relatively
small, and in order to minimize the possible gender and age related effects on gCBF [26, 33]
we included only young healthy males. For comparison we therefor also included data from a
previous study in order to assess the estimates of variability in a dataset where larger variability
is expected. Although applying very similar methods in Dataset 1 and Dataset 2, smaller differ-
ences related to imaging techniques, participants and in study design prohibit direct pooling
of data. Accordingly, it cannot be determined if the larger day-to-day variability in Dataset 2
compared to Dataset 1 is related to the longer interval between study days per se or to other
factors such as the population studied or factors related to the study design and the applied
techniques.
Secondly, it would have been of interest to include measurement of arterial partial pressure
of CO2. Spontaneous variations in end-tidal PCO2 have been shown to induce in particular
intra-subjects gCBF changes in the order of 10–15% per kPa [33, 34]. Data from previous stud-
ies from our laboratory [24, 33] shows day-to-day changes in arterial or end-tidal PCO2 within
±0.4 kPa corresponding to maximum day-to-day gCBF changes of 4–6%. Assessment of arte-
rial PCO2 may obtained by either arterial cannulation or capnography through a closed breath-
ing system, neither of which were considered practical in the experimental setup or generally
performed in MRI studies of cerebral perfusion.
An important limitation to the analysis of Dataset 2 is that we derived CVr from another
population. It would have been optimal if CVr in Dataset 2 had been determined in the same
population using a design similar to that of Dataset 1. As the imaging protocols and setup in
ref [7] and in Dataset 2 were very similar, we used the CVr from [7] to estimate CVw in Dataset
2 assuming that CVr would be similar. We cannot know if this assumption holds true, but we
believe that the differences in data acquisition in [7] and Dataset 2 are minor and it is unlikely
that true CVr in Dataset 2 differs from that in ref [7] to an extend that would alter the main
finding of a much larger CVw in Dataset 2 than in Dataset 1.
We believe that the findings of the present study can provide researchers with valuable
information for planning futures studies involving gCBF measurements. Using the variance
estimates from the Dataset 1, a power calculation shows that in order to detect a 10% differ-
ence in gCBF between two groups, a sample size of 21 in each group is required. Performing
duplicate measurements and including covariates reduces sample size to 17 and 14, respec-
tively. For within-subject changes, adding duplicate measurements reduces sample size from 8
to 6 in order to detect a 10% change, and adding covariates further reduces the required
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sample size to 5 subjects. The analyses, however, do also suggest that such low temporal vari-
ability may only be achieved when studying a homogenous population under strictly con-
trolled conditions, and that the estimated temporal variability cannot be applied to more
heterogeneous populations studied in less well controlled conditions, e.g. large population
based studies [2, 20] or studies of aging involving repeated measurements at different time
points [2, 35].
In conclusion, our results suggest that the contribution of short-term day-to-day variability
to total variability is relatively small compared to between-subject variability of repeated gCBF
measurements when performed close in time and under standardized conditions. The study
also shows that a substantial fraction of the total variability can be attributed to the effects of
easily obtained covariates predominantly by reducing between subject variability. By including
covariates and performing duplicate measurements, the ability to detect temporal changes in
gCBF may be improved in future studies.
Supporting information
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